Return to CBI Antibody Core Home Page
  Return to biothreat/emerging pathogens list
    Return to malaria parasite (malaria (P. falciparum)) ( Plasmodium falciparum ) list


malaria parasite (malaria (P. falciparum)) ( Plasmodium falciparum )
HP1


Antibody Name/Abbreviation: HP1
CBI Antibody Core Code: A0480

"Lot" Number: 1 Position: 100(1521-1620)
% Identical Homology of Target to Mouse Protein: 33% (NP_075019.1| regulator of G-protein signaling 18)
Molecular Weight of fusion protein: N.A. KDa

Target sequence used to make this antibody:
SNEKNECEKHCKQNDNLAAKMQTLFEKFINRCVSLNENED
YETCDKNDKKCKNKVCVLCCKKHDPTTSKELKVLPMNQFK
KIQENEIIECQLQCNMIHSI






Sequence Name: HP1
Full name:
UniGene Number: N.A.
Accession Number: PF14_0723
Source organism: malaria parasite (malaria (P. falciparum)) ( Plasmodium falciparum )
Full length size (aa): 1620
NCBI information page: click here

Full length sequence:
MHHLLFIIWYIILNYYVSGQESATNFYKFIDSFASSTYMSEESGSSAYDA
KRAIQNNPNYWCSSGNHSNDEEITWTGYLNTKGFIKGVKVSWAYSPEFVK
ISVSSDGEKYRTIIPYKKISSNEASFDEIYFFKRLEEAMSIKIGLKNARH
KYFGIREVKLIGGGNPYFLLLSGISSEEEMCLQVEEGLINNDNTSIILDS
CTNALASGDGRELWKTNSNNQVISAFSDPPKCLSVVNLDDLENNKIVLYD
CLRALEDGDGKSNWIFESNSQIRLQKSGDAFCISQKNIYGNIPGIHDILL
NLDVSIYSNSTLDDDHNPDNTIDGNLNSYWASATFTDNYDHLVYLVLDLN
KITDLSRIKIYWEYPPLHYNISVSTDNQNFTVVSENLANPSYITVDSLKN
METRYIKISMIKTHPKHGELGDNFLYGIRSIEVQANNLETVINHCRDAAN
SDDARDKYFVEYITEFDKDLTNKLINLEDDVTKNVSSISDNLSKLEELLP
NIETCLEEKKTYDEELKESKEKANDLNNKLSLLTSVNVNTLDSDILKLGI
LPGDSYNFPANDCAVIKNVQENPLSGFYWIKPKCSPEPLRVYCDMDSSTS
IYIWNGNPPKSPDHLITNMINSVNDIRQHCAEVGLQPLILRSKNQLNSLI
ISLKKIGYSLNGKVNIPLAYDYSCDHGSCSGRFHDLLNGNIDISTLIYLK
ASESPDSTKVRQTAGISYDDGSFKFFNLETSDISAIVCSTNSTENDSALQ
YLSINCETTGMEDSFHSIVNTNIVVLCPLGCDDEKYHDASIYGSRGTYSD
NSSICRAAIHSDIIDNKGGLVNVTIESGMDHYVGSINNNIESISLNKNEK
GLLDIIPEEKEGTNNIREESSIFHHKTIRVSSLIEDCPLDLFLFNQTSFL
EKGNNIRNNKGTELKYNDDENMTVKNFHELISNLMENIDAIHGVDSSVIS
IVQEETIRIIEKTKKELKPADMLSKKQIEDAMNLYNLTENLAIYLYDLSS
KYIQDLEKLKNTLEELKGAQKVAHNFGTFKLNYETMNFSTHFSLFDSNLI
KNKESVWGYSDTNILGHENSIGQMNSVSSQEIGEGYYAKLKGLNFYDFDF
NISVLSRGTGCLGVVFRAKDDFNFYLFDICDKDGTKRLSKVENGQVHILK
KVVNSDVTLNNQWNKYKIITKHANIDIYEVDKDNNMIKILSSLDERFLSG
TVGLYSQIYGLGTFFDDLEVIALPCTQLSELNTLNKNVKSNCPYYKENYL
NNLMSYDIIYNPNNYFNWNVEKENEQNYLLCSKNEEEVKNAKDEKDIYTI
VLLKLRECTDGTFNFDIQVSDDETGNISKKLSYIYILFHYKDENNFNALE
MKDGKLAFLTNKNGKSFILSERNEEENDNNKNIEKRFTFVQNEWIHVNLH
FDKSTFKVIIITNNNEDKFVLSAKSRNDVPLGKVGFLVHNFDEVKFDSIL
LNSPTITKVDENFLQVKSKTWANCEDSVHVLHRRFSCETDIYPNETKEKH
IKCIKNFCKECCLYHTQLLDSNEKNECEKHCKQNDNLAAKMQTLFEKFIN
RCVSLNENEDYETCDKNDKKCKNKVCVLCCKKHDPTTSKELKVLPMNQFK
KIQENEIIECQLQCNMIHSI





Questions? Click here for answers.


© Monday, February 16, 2009 by the CBI Antibody Core and the Center for Biomedical Inventions, University of Texas Southwestern Medical School.